A cross-border acquirer enters advanced negotiations to buy a Netherlands-based distribution group. The commercial logic is compelling. The window for closing is narrow. Then the competition authority opens a preliminary review – and the timeline begins to slip.
This case study examines an anonymised M&A transaction in the Netherlands involving a besloten vennootschap (BV – a Dutch private limited company) as the target entity. The deal required competition clearance under Dutch merger control rules, careful structuring of the share purchase agreement, and coordination with a notaris (Dutch civil law notary) for transfer execution. Closing was achieved within a renegotiated timeline after targeted remedies were offered to the Autoriteit Consument en Markt (ACM – the Netherlands Authority for Consumers and Markets).
This study outlines the client situation, the legal strategy deployed, the key milestones reached, the complications encountered, and three transferable lessons for advisers and acquirers in similar cross-border matters.
Client profile and the challenge
The client was a Western European industrial group structured as a naamloze vennootschap (NV – a Dutch public limited company analogue used in their home jurisdiction). The target was a Netherlands-incorporated BV operating across three EU member states. The transaction was structured as a full share acquisition.
Two challenges arose immediately. First, combined Dutch market turnover thresholds triggered mandatory pre-merger notification to the ACM under Dutch competition legislation. Second, the target's existing shareholders held minority protections under the company's articles – protections that required consent mechanics to be built directly into the share purchase agreement (SPA).
The client had previously relied solely on EU-level merger control analysis. They had not assessed whether Dutch domestic thresholds were independently met. That oversight was identified during due diligence – specifically during a review of the target's Netherlands-registered revenue streams at the Kamer van Koophandel (KvK – Dutch Chamber of Commerce). The risk of proceeding without clearance would have exposed the transaction to prohibition and the client to material financial penalties under Dutch competition legislation.
Our M&A advisory practice in the Netherlands was engaged to restructure the deal timeline, manage the regulatory notification process, and rebuild the SPA closing conditions to reflect the new sequence.
Strategy and key milestones
The team adopted a three-phase approach: regulatory sequencing first, SPA restructuring second, and closing mechanics third.
Phase one focused on the ACM notification. A complete pre-notification package was assembled, including market definition analysis, combined market share data, and an assessment of competitive effects in the relevant product and geographic markets. The ACM operates a two-phase review process. Phase one results in a decision within a defined statutory period. Phase two – triggered when the authority identifies serious concerns – extends the timeline considerably.
The authority's initial assessment raised concerns about vertical integration in one sub-market. Rather than wait for a formal phase two opening, the team proposed a targeted behavioural remedy: a supply access commitment to specific downstream customers for a defined period. The ACM accepted this remedy at the close of phase one. That outcome preserved the original commercial value of the deal and avoided the delay that a full phase two review would have caused.
Phase two addressed the SPA. The original draft had treated ACM clearance as a standard condition subsequent. The revised structure made clearance a condition precedent with a long-stop date, automatic termination triggers, and a reverse break fee payable by the seller if the target's representations caused the clearance to fail. Representations and warranties relating to the target's market conduct were expanded substantially. The closing conditions were reordered so that KvK registration steps and notarial transfer could only be initiated after written confirmation of ACM clearance.
Phase three was the notarial closing. Under Dutch corporate legislation, a transfer of shares in a BV requires execution before a Dutch notaris. The notarial deed of transfer was prepared in parallel with the regulatory process. On the date clearance was confirmed, the deed was executed and the KvK register was updated within 24 hours. The deal closed without further complication.
For context on the corporate law dimensions involved, our corporate law practice in the Netherlands covers BV and NV governance, shareholder rights, and notarial transfer procedures in detail.
Complications and how they were addressed
Three complications arose during the process, each with transferable significance.
The first was a minority shareholder objection. One existing shareholder of the target BV held tag-along rights under the articles. That shareholder initially contested the valuation used in the SPA. The dispute was resolved through a structured price adjustment mechanism – not litigation before the Rechtbank (Dutch District Court) – because the parties agreed a binding independent expert determination clause. This preserved the closing timeline and avoided the uncertainty of Dutch civil procedure.
The second complication was a due diligence gap in the target's intellectual property licences. Several licences contained change-of-control clauses requiring third-party consent on share transfer. These had not been flagged in the seller's initial disclosure. Once identified, the team mapped each clause against the closing structure and obtained consents before the notarial transfer date. Had these consents been sought post-closing, the target's operational continuity would have been at risk.
The third complication involved cross-border tax structuring. The acquirer's home jurisdiction imposed a withholding tax on dividends paid by a Dutch BV under existing treaty provisions. A pre-closing restructuring step – inserting an intermediate holding entity – addressed this exposure. Dutch tax legislation and the applicable bilateral tax treaty were both considered. The restructuring was completed before the notarial deed was executed, ensuring the post-acquisition structure was efficient from day one.
Dutch courts, including the Hoge Raad (Supreme Court of the Netherlands), have consistently held that parties bear the consequences of undisclosed material facts in commercial acquisitions. That body of case law reinforced the importance of the expanded representations and warranties negotiated into the revised SPA.
To explore how regulatory clearance strategies compare across jurisdictions, see our related case study on M&A transaction structuring in Portugal.
To discuss how competition clearance strategy applies to your acquisition in the Netherlands, reach out to info@ferrazwhitmore.com.
Three transferable lessons
Lesson 1 – Assess domestic thresholds independently of EU merger control. Many cross-border acquirers assume that EU-level analysis is sufficient. The Netherlands has its own competition legislation with domestic notification thresholds. These thresholds can be met even when the transaction falls below EU merger regulation levels. Missing this assessment creates a real risk of gun-jumping – proceeding to close before mandatory clearance is obtained. The consequences include potential prohibition, fines, and the possibility that closing steps already taken are deemed void.
Lesson 2 – Build regulatory risk into the SPA before negotiations close. Treating competition clearance as an afterthought in SPA drafting is a common and costly mistake. Clearance conditions, long-stop dates, reverse break fees, and remedy allocation provisions should be negotiated at term sheet stage. A well-drafted SPA allocates regulatory risk clearly between buyer and seller. It also specifies which party controls the remedy negotiation with the authority – a point that frequently becomes contentious when remedies affect the target's business model.
Lesson 3 – Coordinate due diligence, regulatory filing, and notarial closing as a single sequenced process. In Dutch M&A transactions, the notarial transfer step is not merely administrative. It is the legal moment of title transfer for BV shares. Coordinating the KvK registration update, the ACM clearance confirmation, and the notarial deed execution requires tight project management. Gaps between these steps create windows of legal uncertainty. Running them as a sequenced single process eliminates that risk and protects both parties.
About Ferraz & Whitmore
Ferraz & Whitmore is an international law firm based in Lisbon, advising business clients across 46 jurisdictions. Our M&A practice covers the full transaction lifecycle in the Netherlands and across Europe – from due diligence and SPA negotiation to competition clearance and notarial closing. We combine Portuguese civil law expertise with English common law tradition to deliver cross-border M&A solutions for industrial groups, institutional investors, and international businesses. The firm's M&A team has advised on share purchase transactions across both civil law and common law systems, including matters before the ACM and equivalent competition authorities in multiple EU member states. Engaging a lawyer in the Netherlands with cross-border M&A experience is essential when regulatory clearance conditions interact with complex closing mechanics. As an international law firm with a Netherlands practice, Ferraz & Whitmore supports acquirers from initial structuring through to post-closing integration. To discuss your transaction, contact us at info@ferrazwhitmore.com.
Disclaimer: This publication is provided for informational purposes only and does not constitute legal advice. The information herein should not be relied upon as a substitute for professional legal counsel tailored to your specific circumstances. Ferraz & Whitmore assumes no liability for actions taken or not taken based on the contents of this material. For advice regarding your particular situation, please contact info@ferrazwhitmore.com.